Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review.

CONCLUSIONS: This is the first systematic review showing encouraging results for the use of all three main categories of monoclonal antibodies in CRSwNP patients and highlights the need for further well-designed and with larger sample sizes RCTs. PMID: 29396960 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29396960?dopt=Abstract

Source: Rhinology - February 7, 2018 Category: ENT & OMF Tags: Rhinology Source Type: research